Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
Scores, valuations, and signals for Crossbow Therapeutics, Shein, and 370+ companies. 5-min read every Tuesday.
Biotech company developing precision antibody therapies for cancer treatment
| Industry | Biotech / Oncology |
| Stage | series_e |
| IPO Status | Pre-IPO |
| Valuation | $1.8B |
| Total Funding | $450M |
| Headquarters | Cambridge, MA |
Shein is the world's largest fast fashion company, valued at $66B with $5.2B raised. Track IPO readiness score, funding history, and public market timeline.
| Industry | E-Commerce |
| Stage | Pre-IPO |
| IPO Status | Pre-IPO |
| Valuation | $30-50B |
| Total Funding | $5.2B |
| Headquarters | Singapore |
Complete funding history, cap table, S-1 analysis, and investor breakdown for any company. Instant PDF download.
Or buy any single company report for $19
Crossbow Therapeutics is valued at $1.8B. Shein is valued at $30-50B. Both figures are based on the most recent funding rounds tracked by TechStackIPO.
Crossbow Therapeutics is currently pre-IPO. Shein filed an S-1 in June 2024 and is actively in the IPO pipeline. Track both companies on TechStackIPO for S-1 filings, roadshow announcements, and IPO date updates.
Crossbow Therapeutics has raised $450M. Shein has raised $5.2B.
Crossbow Therapeutics operates in Biotech / Oncology, while Shein operates in E-Commerce.
Crossbow Therapeutics is a Biotech / Oncology company valued at $1.8B with $450M raised. Shein is a E-Commerce company valued at $30-50B with $5.2B raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor access options.
Accredited investors can access pre-IPO shares in Crossbow Therapeutics and Shein through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.